RCM

RA Capital Management Portfolio holdings

AUM $5.94B
This Quarter Return
+1.05%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$6.63B
AUM Growth
+$6.63B
Cap. Flow
-$82.7M
Cap. Flow %
-1.25%
Top 10 Hldgs %
50.25%
Holding
100
New
18
Increased
9
Reduced
13
Closed
18

Top Buys

1
VOR icon
Vor Biopharma
VOR
$479M
2
TIL icon
Instil Bio
TIL
$122M
3
EWTX icon
Edgewise Therapeutics
EWTX
$84.9M
4
BOLT icon
Bolt Biotherapeutics
BOLT
$78.3M
5
MCRB icon
Seres Therapeutics
MCRB
$76.1M

Top Sells

1
ARVN icon
Arvinas
ARVN
$312M
2
TGTX icon
TG Therapeutics
TGTX
$195M
3
NVAX icon
Novavax
NVAX
$143M
4
KROS icon
Keros Therapeutics
KROS
$132M
5
FPRX
Five Prime Therapeutics, Inc.
FPRX
$72.9M

Sector Composition

1 Healthcare 95.53%
2 Financials 0.47%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MCRB icon
26
Seres Therapeutics
MCRB
$162M
$76.1M 1.15%
+3,694,193
New +$76.1M
SPRY icon
27
ARS Pharmaceuticals
SPRY
$1.08B
$76M 1.15%
1,742,186
– –
IGMS
28
DELISTED
IGM Biosciences
IGMS
$75.4M 1.14%
982,723
– –
KALA icon
29
KALA BIO
KALA
$105M
$73.3M 1.11%
10,874,613
– –
OLMA icon
30
Olema Pharmaceuticals
OLMA
$432M
$71.4M 1.08%
2,150,404
– –
ORTX
31
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$69.2M 1.04%
12,315,213
– –
SLDB icon
32
Solid Biosciences
SLDB
$448M
$68.4M 1.03%
12,367,873
+2,391,304
+24% +$13.2M
DSGN icon
33
Design Therapeutics
DSGN
$339M
$65.4M 0.99%
+2,186,636
New +$65.4M
BDTX icon
34
Black Diamond Therapeutics
BDTX
$164M
$62.8M 0.95%
2,589,904
– –
TRIL
35
DELISTED
Trillium Therapeutics Inc.
TRIL
$56.8M 0.86%
5,290,481
– –
PMVP icon
36
PMV Pharmaceuticals
PMVP
$82.1M
$56.3M 0.85%
1,710,265
– –
CNTB
37
Connect Biopharma
CNTB
$111M
$55.3M 0.83%
+2,991,208
New +$55.3M
CNST
38
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$52.4M 0.79%
2,238,536
+385,790
+21% +$9.02M
CCCC icon
39
C4 Therapeutics
CCCC
$182M
$51M 0.77%
1,377,569
– –
STRO icon
40
Sutro Biopharma
STRO
$85.6M
$48.2M 0.73%
2,118,212
– –
GERN icon
41
Geron
GERN
$893M
$47.6M 0.72%
30,126,299
– –
WVE icon
42
Wave Life Sciences
WVE
$1.27B
$43.6M 0.66%
7,775,207
– –
DYN icon
43
Dyne Therapeutics
DYN
$1.92B
$43.6M 0.66%
2,805,045
– –
VRNA
44
Verona Pharma
VRNA
$9.18B
$42.6M 0.64%
5,100,000
– –
ARDX icon
45
Ardelyx
ARDX
$1.57B
$40.2M 0.61%
6,077,294
-85,792
-1% -$568K
INZY
46
DELISTED
Inozyme Pharma
INZY
$39.7M 0.6%
2,003,653
– –
STSA
47
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$35M 0.53%
5,914,252
+1,232,394
+26% +$7.28M
RLAY icon
48
Relay Therapeutics
RLAY
$709M
$34.6M 0.52%
1,000,000
– –
AKUS
49
DELISTED
Akouos, Inc. Common Stock
AKUS
$31.6M 0.48%
2,281,249
– –
CERE
50
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$30.2M 0.46%
2,200,000
– –
1
2
3 4